1. Home
  2. PJT vs GH Comparison

PJT vs GH Comparison

Compare PJT & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PJT
  • GH
  • Stock Information
  • Founded
  • PJT 2014
  • GH 2011
  • Country
  • PJT United States
  • GH United States
  • Employees
  • PJT N/A
  • GH N/A
  • Industry
  • PJT Investment Managers
  • GH Medical Specialities
  • Sector
  • PJT Finance
  • GH Health Care
  • Exchange
  • PJT Nasdaq
  • GH Nasdaq
  • Market Cap
  • PJT 4.5B
  • GH 4.9B
  • IPO Year
  • PJT N/A
  • GH 2018
  • Fundamental
  • Price
  • PJT $179.29
  • GH $67.16
  • Analyst Decision
  • PJT Hold
  • GH Strong Buy
  • Analyst Count
  • PJT 3
  • GH 16
  • Target Price
  • PJT $187.00
  • GH $57.50
  • AVG Volume (30 Days)
  • PJT 189.8K
  • GH 2.8M
  • Earning Date
  • PJT 10-28-2025
  • GH 07-30-2025
  • Dividend Yield
  • PJT 0.56%
  • GH N/A
  • EPS Growth
  • PJT 54.67
  • GH N/A
  • EPS
  • PJT 5.83
  • GH N/A
  • Revenue
  • PJT $1,537,018,000.00
  • GH $828,849,000.00
  • Revenue This Year
  • PJT $12.16
  • GH $28.07
  • Revenue Next Year
  • PJT $12.52
  • GH $21.61
  • P/E Ratio
  • PJT $30.73
  • GH N/A
  • Revenue Growth
  • PJT 18.48
  • GH 28.74
  • 52 Week Low
  • PJT $116.07
  • GH $20.14
  • 52 Week High
  • PJT $190.28
  • GH $67.42
  • Technical
  • Relative Strength Index (RSI)
  • PJT 54.74
  • GH 77.74
  • Support Level
  • PJT $177.33
  • GH $57.41
  • Resistance Level
  • PJT $186.44
  • GH $62.81
  • Average True Range (ATR)
  • PJT 4.06
  • GH 1.90
  • MACD
  • PJT -0.20
  • GH 0.63
  • Stochastic Oscillator
  • PJT 65.50
  • GH 98.41

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: